Back to results
US 10,233,158 B2Granted
Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
AssigneeParion Sciences, Inc.
InventorMichael R. Johnson
Life of this patent
Estimating the term…
Abstract
The present invention relates to the compound of the formula: or pharmaceutically acceptable salts thereof, as well as compositions containing the same, processes for the preparation of the same, and therapeutic methods of use therefore in promoting hydration of mucosal surfaces and the treatment of diseases including chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, acute and chronic bronchitis, cystic fibrosis, emphysema, and pneumonia.
Claims20
A method of preparing a compound of Formula (I):
- or a salt thereof, the method comprising reacting a compound formula (2):
- or a salt thereof, with a compound of the formula:
- or a salt thereof, wherein:
- Ar is a moiety selected from the group of:
- X is selected from —CH2—, —O—, and —S—;
- n is an integer selected from 0, 1, 2, 3, 4, 5, and 6;
- R is a polyhydroxylated alkyl group having from 3 to 8 carbon atoms;
- R1 is selected from —(CH2)qY and —(CH2)q—O—Y;
- q is an integer selected independently in each instance from 1, 2, 3, 4, 5, and 6;
- and
- Y is a phenyl, naphthyl, or pyridyl ring, with each phenyl, naphthyl, or pyridyl ring substituted by 0, 1, 2, or 3 substituents independently selected from halogen, —OH, —CN, —NO2, —NH2, —NH(C1-C6 alkyl), —N(C1-C6 alkyl)2, C1-C6 alkyl, C1-C6 alkoxy, and —CF3.
8 more elements
Dependencies are inferred from the claim text.